IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
According to IM Cannabis Corp.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.71. At the end of 2022 the company had a P/S ratio of 1.05.
Year | P/S ratio |
---|---|
2023 | 0.71 |
2022 | 1.05 |
2021 | 2.14 |
2020 | 144.89 |
2019 | 0.46 |
2018 | 0.73 |
2017 | 0.02 |
2016 | 0.00 |
2015 | 0.00 |
2014 | 0.00 |
2013 | 0.00 |
2012 | 0.00 |
2011 | 0.00 |
2010 | 0.00 |
2009 | 0.00 |
2008 | 0.00 |
2007 | 0.00 |
2006 | 0.00 |
2005 | 0.00 |
2004 | 0.00 |
2003 | 0.00 |
2002 | 132.62 |
2001 | 152.57 |
2000 | 24.64 |
1999 | 110.93 |
1998 | 33.33 |
1997 | 6.56 |
1996 | 13.46 |